Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection.

Chan MM, Adapala N, Chen C.

PPAR Res. 2012;2012:796235. doi: 10.1155/2012/796235. Epub 2012 Feb 1.

2.

Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections.

Chan MM, Evans KW, Moore AR, Fong D.

J Biomed Biotechnol. 2010;2010:828951. doi: 10.1155/2010/828951. Epub 2010 Feb 10. Review.

3.

Treatment in vitro with PPARα and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice.

Penas F, Mirkin GA, Vera M, Cevey Á, González CD, Gómez MI, Sales ME, Goren NB.

Biochim Biophys Acta. 2015 May;1852(5):893-904. doi: 10.1016/j.bbadis.2014.12.019. Epub 2014 Dec 31.

4.

Statin-induced chronic cholesterol depletion inhibits Leishmania donovani infection: Relevance of optimum host membrane cholesterol.

Kumar GA, Roy S, Jafurulla M, Mandal C, Chattopadhyay A.

Biochim Biophys Acta. 2016 Sep;1858(9):2088-96. doi: 10.1016/j.bbamem.2016.06.010. Epub 2016 Jun 16.

PMID:
27319380
5.

Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages.

Majumdar SB, Bhattacharya P, Bhattacharjee S, Majumder S, Banerjee S, Majumdar S.

Indian J Exp Biol. 2014 Jan;52(1):17-29.

PMID:
24617012
6.

Host resistance to visceral leishmaniasis: prevalence and prevention.

Maran N, Gomes PS, Freire-de-Lima L, Freitas EO, Freire-de-Lima CG, Morrot A.

Expert Rev Anti Infect Ther. 2016;14(4):435-42. doi: 10.1586/14787210.2016.1160779. Review.

PMID:
26934623
7.

Cell biology of host-parasite membrane interactions in leishmaniasis.

Chang KP, Fong D.

Ciba Found Symp. 1983;99:113-37. Review.

PMID:
6357669
8.

Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.

Rai K, Cuypers B, Bhattarai NR, Uranw S, Berg M, Ostyn B, Dujardin JC, Rijal S, Vanaerschot M.

MBio. 2013 Oct 8;4(5):e00611-13. doi: 10.1128/mBio.00611-13.

9.

Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS.

J Immunol. 2010 Jul 15;185(2):929-42. doi: 10.4049/jimmunol.1000866. Epub 2010 Jun 16.

10.

Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages.

Koutsoni O, Barhoumi M, Guizani I, Dotsika E.

PLoS One. 2014 May 15;9(5):e97319. doi: 10.1371/journal.pone.0097319. eCollection 2014.

11.

Leishmania cell surface prohibitin: role in host-parasite interaction.

Jain R, Ghoshal A, Mandal C, Shaha C.

Cell Microbiol. 2010 Apr 1;12(4):432-52. doi: 10.1111/j.1462-5822.2009.01406.x. Epub 2009 Nov 2.

PMID:
19888987
12.

115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.

Choudhury R, Das P, De T, Chakraborti T.

Immunobiology. 2013 Jan;218(1):114-26. doi: 10.1016/j.imbio.2012.02.008. Epub 2012 Feb 16.

PMID:
22440312
13.

Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.

Wadhone P, Maiti M, Agarwal R, Kamat V, Martin S, Saha B.

J Immunol. 2009 Jun 1;182(11):7146-54. doi: 10.4049/jimmunol.0803859.

15.

Integrity of the actin cytoskeleton of host macrophages is essential for Leishmania donovani infection.

Roy S, Kumar GA, Jafurulla M, Mandal C, Chattopadhyay A.

Biochim Biophys Acta. 2014 Aug;1838(8):2011-8. doi: 10.1016/j.bbamem.2014.04.017. Epub 2014 Apr 26.

17.

IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.

Srivastav S, Saha A, Barua J, Ukil A, Das PK.

Eur J Immunol. 2015 Oct;45(10):2787-97. doi: 10.1002/eji.201445336. Epub 2015 Jul 21.

18.

Protozoa: Pathogenesis and Defenses.

Seed JR.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 78.

19.

Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.

Fiuza JA, Gannavaram S, Santiago Hda C, Selvapandiyan A, Souza DM, Passos LS, de Mendonça LZ, Lemos-Giunchetti Dda S, Ricci ND, Bartholomeu DC, Giunchetti RC, Bueno LL, Correa-Oliveira R, Nakhasi HL, Fujiwara RT.

Vaccine. 2015 Jan 3;33(2):280-8. doi: 10.1016/j.vaccine.2014.11.039. Epub 2014 Dec 1.

PMID:
25475955
20.

Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.

McCall LI, Zhang WW, Dejgaard K, Atayde VD, Mazur A, Ranasinghe S, Liu J, Olivier M, Nilsson T, Matlashewski G.

J Proteome Res. 2015 Feb 6;14(2):1033-59. doi: 10.1021/pr5010604. Epub 2015 Jan 13.

PMID:
25536015

Supplemental Content

Support Center